SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral targetShuofeng Yuan, Kwok‐Yung Yuen, Hin Chu et al.|Nature Communications|2019Cited by 259
Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamstersShuofeng Yuan, Jasper Fuk‐Woo Chan, Chris Chung‐Sing Chan et al.|Science|2022Cited by 222
Clofazimine broadly inhibits coronaviruses including SARS-CoV-2Shuofeng Yuan, Kwok‐Yung Yuen, Xin Yin et al.|Nature|2021Cited by 211
Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamstersShuofeng Yuan, Hongzhe Sun, Runming Wang et al.|Nature Microbiology|2020Cited by 199
Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening systemShuofeng Yuan, Kwok‐Yung Yuen, Jasper Fuk‐Woo Chan et al.|Pharmacological Research|2020Cited by 71